Common Causes of Acute Otitis Media
The three most common bacterial pathogens causing acute otitis media are Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis, with the relative frequency of these organisms having shifted following pneumococcal conjugate vaccine introduction. 1
Primary Causative Organisms
Bacterial Pathogens
The bacterial landscape of AOM is well-established through middle ear fluid cultures:
- Bacteria and/or viruses are detected in up to 96% of AOM cases when comprehensive microbiologic testing is used (66% bacteria and viruses together, 27% bacteria alone, 4% virus alone) 1
- The three dominant bacterial pathogens account for the vast majority of cases 1
- Streptococcus pyogenes (Group A streptococcus) causes less than 5% of cases 1
Post-Vaccine Era Shifts
The introduction of pneumococcal conjugate vaccines has fundamentally altered the microbiology:
- In the post-PCV7 era (2007-2009), H. influenzae and S. pneumoniae became nearly equal in frequency 1
- Recent data from 2021-2023 shows H. influenzae now accounts for 52.1% of cases (99.6% nontypeable), while S. pneumoniae accounts for 41.1% 2
- Non-PCV7 serotypes of S. pneumoniae have replaced vaccine serotypes, maintaining overall pneumococcal presence 1
Viral Contribution
AOM most frequently occurs as a consequence of viral upper respiratory tract infection, which leads to eustachian tube inflammation, negative middle ear pressure, and movement of nasopharyngeal pathogens into the middle ear 1. Respiratory viruses act as both direct pathogens and facilitators of bacterial infection.
Geographic Variations
While the core pathogens remain consistent globally, regional differences exist:
- In Thailand (pre-Hib vaccine), Haemophilus influenzae type b represented 62% of all H. influenzae isolates, an unexpectedly high burden 3
- In Colombia, nontypeable H. influenzae (87% of H. influenzae cases) and S. pneumoniae were equally prevalent 4
- These variations underscore the impact of vaccination programs on local epidemiology
Clinical Implications
When treating AOM empirically, clinicians must consider that both S. pneumoniae and nontypeable H. influenzae are now approximately equal in prevalence, with increasing antibiotic resistance patterns in both organisms 2. This dual threat justifies the continued recommendation for high-dose amoxicillin as first-line therapy, which maintains activity against most strains of both pathogens 1.
The pathogenesis begins with viral upper respiratory infection, making AOM fundamentally a polymicrobial disease in most cases, though bacterial pathogens drive the need for antibiotic therapy when present.